Oral administration of a dominant T-cell determinant peptide inhibits allergen-specific TH1 and TH2 cell responses in Cryj2-primed mice.
J. Allergy Clin Immunol. (1999), 102(6), 961-967
- DOI
- 10.1016/S0091-6749(98)70334-3
- ID情報
-
- DOI : 10.1016/S0091-6749(98)70334-3